Zeno I. Pasquini

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients.

Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients.

Journal: The Journal of antimicrobial chemotherapy

Published: February 11, 2026

Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental Study.

Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental Study.

Journal: Open forum infectious diseases

Published: October 23, 2025

Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study.

Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 30, 2025

ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients.

ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 19, 2024

What Is the Impact of Anti-Enterococcal Empirical Therapy on Survival of Patients With Enterococcal Bloodstream Infections?

What Is the Impact of Anti-Enterococcal Empirical Therapy on Survival of Patients With Enterococcal Bloodstream Infections?

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 13, 2024

Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study.

Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study.

Journal: PloS one

Published: December 04, 2024

Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections.

Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections.

Journal: NPJ digital medicine

Published: July 23, 2024

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study.

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study.

Journal: BMC infectious diseases

Published: June 17, 2023

A modular phage vector platform for targeted photodynamic therapy of Gram-negative bacterial pathogens.

A modular phage vector platform for targeted photodynamic therapy of Gram-negative bacterial pathogens.

Journal: iScience

Published: May 17, 2023

Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.

Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.

Journal: EClinicalMedicine

Published: May 03, 2023

Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.

Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.

Journal: Hematological oncology

Published: April 21, 2023

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis.

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis.

Journal: Antibiotics (Basel, Switzerland)

Published: March 26, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026